PauloAcFontesMDChief Medical Officer, LyGenesis

PubMed

• 12 citations
  Development of Ectopic Livers by Hepatocyte Transplantation Into Swine Lymph Nodes.
  Paulo Fontes, Junji Komori, Roberto Lopez, Wallis Marsh, Eric Lagasse
  Liver Transplantation. 2020-12-01
• 7 citations
  The Evolution of Oxygen Carrier Solutions for Machine Perfusion.
  Paulo Fontes
  Transplantation. 2017-11-01
• 1 citations
  Giant Left Ventricle Outflow Tract Pseudoaneurysm after Ross Procedure.
  Sílvia Leão, Sofia Carvalho, Hélder Ribeiro, Paulo Fontes, J. Ilídio Moreira
  Arquivos Brasileiros De Cardiologia. 2017-04-01

Journal Articles

• Liver preservation with machine perfusion and a newly developed cell free oxygen carrier solution under subnormothermic conditions  
  109. Fontes P, Lopez R, van der Plaats A, Vodovotz Y, Minervini M, Scott V, Soltys K, Shiva S, Paranjpe S, Sadowsky D, Barclay D, Zamora R, Stolz D, Demetris AJ, Micha..., American Journal of Transplantation 2015; 15:381-394., 1/23/2015
• Objective radiologic assessment of body composition in patients with end-stage-liver-disease: going beyond the BMI.  
  Cruz RJ, Dew MA, Myaskovsky L, Goodpaster B, Fox K, Fontes P, DiMartini A, Transplantation, 1/1/2013
• Early treatment of depressive symptoms and long term survival after liver transplantation.  
  Rogal SS, Dew MA, Fontes P, DiMartini AF, American Journal of Transplantation, 1/1/2013
• Re-examination of the lymphocytotoxic crossmatch in liver transplantation: can C4d stains help monitoring?  
  Lunz J, Ruppert KM, Cajaiba MM, Isse K, Bentlejewski CA, Minervini M, Nalesnik MA, Randhawa P, Rubin E, Sasatomi E, DeVera ME, Fontes P, Humar A, Zeevi A, Demetris AJ, American Journal of Transplantation, 1/1/2012
• Screening for head and neck cancer in the liver transplant candidates: a review of 11 years of experience at the University of Pittsburgh.  
  Dedhia RC, Grandis JR, Fontes PA, Johnson JT, Weissfeld J, Layngoscope, 1/1/2012
• Liver Allograft Pathology. Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational to...  
  Banff Working Group, Liver Transplantation, 1/1/2012
• Surgical management of gastrointestinal posttransplant lymphoproliferative disorders in liver transplant recipients.  
  Cruz RJ, Ranachandra S, Sasatomi E, DiMartini A, DeVera M, Fontes P, Highes C, Humar A, Transplantation, 1/1/2012
• Role of baseline ecochardiography in the preoperative management of liver transplant candidates.  
  Harinstein ME, Iyer S, Mathier MA, Flaherty JD, Fontes P, Planinsic RM, Edelman K, Katz WE, Lopez-Candales A, American Journal of Cardiology, 1/1/2012
• Machine perfusion with a new oxygen-carrier solution: the future of liver preservation.  
  Fontes PA, Marsh JW, Lopez RC, Soltys K, Cruz RJ, van der Plaats A, Light WR, Scott VL, Damiani D, Venkatmaran R, Sruti S, Minnervini M, Demetris AJ, Hepatology, 1/1/2012
• Combined heart and liver transplantation in a patient with situs ambiguous.  
  Horai T, Bhama JK, Fontes P, Toyoda Y, Annals Thoracic Surgery, 1/1/2011
• Early trajectories of depressive symptoms after liver transplantation for alcoholic liver disease predict long-term survival  
  Di Martini A, Dew MA, Chaiffetz D, Fitzgerald MG, DeVera M, Fontes P, American Journal of Transplantation, 1/1/2011
• Does simultaneous lung-liver transplantation provide and immunologic advantadge compared with isolated lung transplantation?  
  Bhama JK, Pilewski JM, Zaldonis D, Fontes PA, DeVera ME, Shigemura N, Bermudez CA, Toyoda Y, McCurry, J Thorac Cardiovasc Surg, 1/1/2011
• Post transplant biliary complications in the pre- and post- model for end-stage liver disease era.  
  Sundaram V, Jones DT, Shah NH, DeVera ME, Fontes P, Marsj JW, Humar A, Ahmad J, Liver Transpl, 1/1/2011
• One thousand consecutive primary liver transplants under tacrolimus: a 17- to 20- longitudinal follow up.  
  Jain A, Singhal A, Fontes P, Mazariegos G, DeVera ME, Cacciarelli T, Lopez RC, Sindhi R, Humar A, Marsh JW, Transplantation, 1/1/2011
• Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts.  
  Tao R, Ruppert K, Cruz R, Malik SM, Shaikh O, Ahmad J, DiMartini A, Humar A, Fontes P, DeVera M, Liver Transplantation, 1/1/2010
• Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis.  
  Malik SM, DeVera ME, Fontes P, Shaikh O, Sasatomi E, Ahmad J, Liver Transplantation, 12/1/2009
• Treatment of hepatic epithelioid hemangioendothelioma: a single-institution experience with 25 cases.  
  Cardinal J, DeVera ME, Marsh JW, Steel JL, Geller DA, Fontes P, Nalesnik M, Gamblin TC, Archives of Surgery, 11/1/2009
• Hepatobiliary effects of 90 yttrium microsphere therapy for unresectable hepatocellular carcinoma.  
  Nalesnik M, Federle M, Buck D, Fontes P, Carr BI, Human Pathology, 1/1/2009
• Liver biopsy findings from healthy potential living donors: reaspns for disqualification, silent diseases and correlation with liver injury tests.  
  Minervini MI, Ruppert K, Fontes P, Volpes R, Vizzini G, DeVera M, Gruttadauria S, Miraglia R, Pipitone L, Marsh JW, Marcos A, Gridelli B, Demetris AJ, Journal of Hepatology, 1/1/2009
• Liver transplanttion using donation after caridac death donors: long-term follow-up from a single center.  
  DeVera M, Lopez RS, Dvorchik I, Campos S, Morris W, Demetris AJ, Fontes P, Marsh JW, American Journal of Transplantation, 1/1/2009
• Outcome after liver transplantation for NASH cirrhosis.  
  Malik SM, DeVera M, Fontes P, Shaikh O, Ahmad J, American Journal of Transplantation, 1/1/2009
• Extrahepatic factor VIII production in transplant recipient of hemophilia donor liver.  
  Madeira CL, Layman ME, DeVera M, Fontes PA, Ragni MV, Blood, 1/1/2009
• Simultaneous pancreatectomy and liver transplantation: a single institution experience.  
  Duphar R, DeVera M, Marsh JW, Fontes PA, Steel JL, Zeh HJ, Gamblin TC, Heaptobiliary, 1/1/2009
• Extrahepatic portal vein aneurysm: report ox six cases and review of the literature.  
  Cho SW, Marsh JW, Fontes PA, Daily MF, Nalesnik M, Tublin M, DeVera M, Geller DA, Gamblin TC, Journal Gastroenterology and Surgery, 1/1/2008
• Age, model for end-stage liver disease score, and organ functioning predict post transplant Tacrolimus neurotoxicity.  
  DiMartini A, Fontes P, Dew MA, Lotrich FE, DeVera M, Liver Transplantation, 1/1/2008
• Join now to see all

Books/Book Chapters

• Living Donor Transplantation 
  Chapter: Adult recipient outcomes: the Pittsburgh experience with Alemtuzumab preconditioning and Tacrolimus monotherapy – two year otcomes 
  Page 207 - 216Tan H, Tom K, Thai N, Fontes P, DeVera M, Donaldson J, Dvorchik I, Marcos AInforma Healthcare USA Inc2007
• Transplantation of the Liver 
  Chapter: Cell migration, chimerism and graft acceptance, with particular reference to the liver. 
  Page 1183 - 1198Starzl TE, Murase N, Demetris AJ, Trucco M, Eghtesad B, Fontes P, Abu-Elmagd K, Marcos M, Fung JJElsevier and Saunders2005
• Methods in Cell Transplantation 
  Chapter: Human vertebral bodies as a source of bone marrow for cell augmentation in whole organ allografts 
  Page 619 - 626Fontes PA, Ricordi C, Rao AS, Rybka WB, Dodson SF, Broznick B, Ukah FO, Ball ED, Fung JJ, Starzl TER.G. Landes Company, Austin, TX1995
• Clinical Transplants 1995 
  Chapter: The current status of hepatic transplantation at the University of Pittsburgh. 
  Page 145 - 170Abu-Elmagd K, Fung JJ, Todo S, Rao AS, Reyes J, Demetris AJ, Marzariegos G, Fontes P, McMichael J, Furukawa H, Dodson F, Jain A, Pinna A, Marsh W, Marino I, Gayowsky T...Editors: Terasaki and Cecka.UCLA Tissue Typing Laboratory, Los Angeles, CA1995
• Clinical Transplants 1993 
  Chapter: Recent Advances in hepatic transplantation at the University of Pittsburgh. 
  Page 137 - 152Abu-Elmagd K, Bronsther O, Jain A, Irish W, Fung JJ, Ramos H, Marino I, Dodson F, Selby R, Doyle H, Furukawa H, Gayowski T, Nour B, Reyes J, Pinna A, Rao AS, Fontes PA...Editors: Terasaki and Cecka.UCLA Tissue Typing Laboratory, Los Angeles, CA1994
• Pancreatic Islet Cell Transplantation. 
  Chapter: Islet transplantation in diabetes: The Pittsburgh Experience 
  Page 447 - 452Ricordi C, Carroll PB, Tzakis AG, Alejandro R, Zeng Y, Rilo HLR, Fontes PA, Shapiro R, Fung JJ, Starzl TEEditors: Ricordi C.R.G. Landes Company, Austin1992
• Join now to see all

Abstracts/Posters

• Machine perfusion with a new cell-free oxygen carrier solution provides effective ex-vivo oxygenation, minimizes ischemia reperfusion injuries and downregulates genes ...
  Fontes PA, Marsh JW, Lopez RC, van der Plaats A, Light WR, Paranjpe S, Shiva S, Vodovotz Y, Michaolpoulos G, 16th Congress, European Society for Organ Transplantation, Vienna, Austria, 9/1/2013
• Liver preservation with machine perfusion under full oxygenation using a new cell free oxygen carrier solution.
  Fontes PA, Marsh W, Lopez R, Soltys K, Scott V, A van der Plaats, W Light, S Shiva, M Minnernvinni, Demetris AJ, American Journal of Transplantation, 1/1/2013
• American Transplant Congress, American Journal of Transplantation
  Harinstein ME, Katz WE, Mathier MA, Fontes PA, Planinsic RM, Edelman K, Lopez-Candales A, American College of Cardiology, Chicago, IL, 3/1/2012
• Machine perfusion with a new oxygen-carrier solution: the future of liver preservation.
  Fontes PA, Marsh JW, Lopez RC, Soltys K, Cruz RJ, van der Plaats A, Light WR, Scott VL, Damiani D, Venkatmaran R, Sruti S, Minnervini M, Demetris AJ, Hepatology, 1/1/2012
• Posterior reversible encephalopathy syndrome (PRES) in liver transplant patients: incidence, risk factors and initial management.
  Cruz RJ, DiMartini A, Akhavanheidari M, Fontes P, Boardman J, Humar A, Bartynski., American Transplant Congress, American Journal of Transplantation, 1/1/2011
• Gastrointestinal tract involvement of post transplant lymphoproliferative disorders (PTLD) in liver transplant patients: Incidence, initial management and outcomes.
  Cruz RJ, Fontes P, Sasatomi E, Lopez RC, Humar A, DeVera M, American Transplant Congress, American Journal of Transplantation, 1/1/2010
• Post transplant biliary complications in the pre and post MELD era.
  Sundaran V, Jones D, Shah N, DeVera M, Fontes P, Ahmad J, American Transplant Congress, American Journal of Transplantation, 1/1/2010
• American Transplant Congress, American Journal of Transplantation
  Venkataramanan R, Fontes P, DeVera M, Humar A, American Transplant Congress, American Journal of Transplantation, 1/1/2010
• The impact of treatment with Interferon-Alfa and Ribavarin (IF/R) on CD4 T-Cell immune responses measured by ImmunKnow in HCV patients.
  Nachmany I, Zeevi A, Lunz J, Fontes P, Marsh JW, eVera M, American Transplant Congress, American Journal of Transplantation, 1/1/2009
• Hepatitis C recurrence is not adversely affected by the use of DCD livers.
  Tao R, Lopez RC, Marsh JW, Blisard DM, Fontes P, DeVera M, American Transplant Congress, American Journal of Transplantation, 1/1/2009
• Risk factors for poor outcome after liver transplantation in obese patients.
  Mavrakis A, Malik S, DeVera M, Tom K, Fontes P, Marcos A, Ahmad J, American Transplant Congress, American Journal of Transplantation, 1/1/2008
• Prognostic factors of acute renal failure early after liver transplantation.
  Dvorchik I, Fontes P, Tom K, Lopez R, Sharma V, Marsh W, Marcos A, DeVera M, American Transplant Congress, American Journal of Transplantation, 1/1/2008
• Acute renal failure after liver transplantation: donor and recipient associated risk factors.
  DeVera M, Tom K, Lopez R, Patel S, Fontes P, Marsh W, Marcos A, Dvorchik I, American Transplant Congress, American Journal of Transplantation, 1/1/2008
• Pre-transplant transjugular portosystemic shunt does not adversely affect outcome after orthotopic liver transplantation.
  Nasr J, Malik S, DeVera M, Tom K, Fontes P, Marcos A, Ahmad J, American Transplant Congress, American Journal of Transplantation, 1/1/2008
• Incidence and outcome of recurrent NASH in liver transplant recipients.
  Malik SM, DeVera M, Chadalavada R, Sass D, Fontes P, Marcos A, Ahmad J, American Journal of Transplantation, 1/1/2007
• Living donor liver transplantation under Alemtuzumab pre-conditioning and Tacrolimus monotherapy.
  Tan H, Tom K, Tai N, Fontes P, DeVera M, Sharma V, Donaldson J, Dvorchik I, Starzl TE, Marcos A, American Journal of Transplantation, 1/1/2007
• Factors predicting of poor outcome after liver transplantation for NASH.
  Malik S, DeVera M, Chadalavada R, Sass D, Fontes P, Marcos A, Ahmad J, American Journal of Transplantation, 1/1/2007
• Evolution of the surgical management of portomesenteric venous thrombosis (PMVT): 25 years of experience at a single center.
  Abu-Elmagd K, Costa G, Haider H, Bond G, Wu T, Fontes P, Marsh W, Marcos A, Starzl TE, American Journal of Transplantation, 1/1/2007
• Use of 90Yttrium microspheres to downstage hepatocelular carcinoma and as a bridge to liver transplantation.
  Daily M, Gamblin C, Marsh W, Geller D, Nalesnink M, Fontes P, Amesur N, Carr B, DeVera M, American Journal of Transplantation, 1/1/2007
• Financial comparison of adult-to-adult liver transplantation from living -vs deceased- donors.
  Mohanka R, Kayler L, Tom K, Fontes P, Dvorchik I, DeVera M, Soltys K, Blisard D, Sharma V, American Journal of Transplantation, 1/1/2007
• Outcome of regenerative hyperplasia after liver transplantation
  Malik S, Sass D, Behari J, Chadalavada R, DeVera M, Fontes P, Marcos A, Demetris AJ, Ahmad J, American Journal of Transplantation, 1/1/2007
• Financial comparison of adult-to-adult liver transplantation from living- vs decased-donors
  Kayler L, Tom K, Fontes P, Dvorchik I, Marcos A, Liver Transplantation, 1/1/2007
• Living donor liver transplantation under Alemtuzumab pre-conditioning and Tacrolimus monotherapy: two-year outcomes.
  Tan H, Tom K, Thai N, Fontes P, DeVera M, Sharma V, Donaldson J, Dvorchik I, Starzl TE, Marcos A, Liver Transplantation, 1/1/2007
• Systemic adjuvant chemotherapy for stage III or IV hepatocellular carcinoma post liver transplantation improves survival.
  Xiao G, Tai S, Fontes P, Gamblin C, Geller D, Marsh JW, Nalesnik M, Carr B, DeVera M, Liver Transplantation, 1/1/2007
• Bloodless Coup: Outcomes After Liver Transplantation in Jehovah’s Witness Patients.
  Jaideep Behari, Paulo Fontes, Michael DeVera, Kusum Tom, Amadeo Marcos, and Jawad Ahmad, The First Joint International Transplant Meeting., John B. Hynes Convention Center, Boston, MA, 7/1/2006
• Join now to see all

Lectures

• Ex-vivo therapy as a way to revolutionize organ preservation 
  Meeting with Senator Pat Toomey hosted by Dean Arthur Levine, MD at the McGowan Institute of Regener - 7/1/2013
• Hepatocyte transplants into the per-hepatic lymph nodes. 
  KIN Life Science Advisory Committee Meeting, Office of Enterprise Development, Gardner Steel Confere - 7/1/2013
• Machine perfusion as a new model for drug development in liver diseases. 
  Kadmon Pharmaceuticals, New York, NY - 7/1/2013
• Machine perfusion for organ preservation and bioengineering. 
  Yearly meeting with McGowan family trustees, McGowan Institute of Regenerative Medicine, BSP II, Pit - 6/1/2013
• Machine Perfusion for Liver Preservation 
  Starzl Transplantation Institute, LHAS Auditorium, Montefiore Hospital - 5/1/2013
• Concurrent Session 40: Non-Organ Specific: Organ Preservation/Ischemia Reperfusion Injury; Liver preervation with machine perfusion under full oxygenation using a new ... 
  American Transplant Congress, Seattle, WA. - 5/1/2013
• The Pittsburgh experience: subnormothermic liver perfusion. 
  Expert Group Meeting on Liver Perfusion at the American Transplant Congress, Seattle, WA - 5/1/2013
• Future therapies for end-stage-organ-diseases: are we there yet? 
  Global Stretegy Interface, Buidling a sustainable economy – A learning journey for Abu Dhabi Governm - 4/1/2013
• Pipeline of research developments for liver diseases. 
  American Liver Foundation on Western PA, Research Meeting, McGowan Institute of Regenerative Medicin - 4/1/2013
• New therapeutic alternatives for end stage liver disease. 
  American Liver Foundation, PSC group, Research Meeting, McGowan Institute of Regenerative Medicine, - 4/1/2013
• PA. Machine perfusion with a newly developed oxygen carrier solution: pre-clinical experience with livers. 
  12th Scientific Retreat, McGowam Institute of Regenerative Medicine, Nemacolin, Farmington, PA - 3/1/2013
• Machine perfusion and the future of organ preservation. 
  McGowam Institute of Regenerative Medicine, Meeting with the Committee for Oversight in Organ Transp - 2/1/2013
• Machine perfusion for organ preservation. 
  University Medical Center of Groningen, School of Medicine, Surgical Grand Rounds. Groningen, Nether - 12/1/2012
• Machine perfusion with a new oxygen carrier solution. 
  63rd Meeting of the American Association for Liver Diseases. Boston, MA - 11/1/2012
• McGowan Institute of Regenerative Medicine, NIH site visit, P41 Center for Whole Organ Engineering, Invited Speaker 
  Bridgeside Point, Pittsburgh, PA - 10/1/2011
• McGowan Institute of Regenerative Medicine, Heinz Foundation meeting, Invited Speaker 
  Bridgeside Point, Pittsburgh, PA - 7/1/2011
• McGowan Institute of Regenerative Medicine, Board Meeting, Invited Speaker 
  Duquesne Club, Pittsburgh, PA - 5/1/2011
• Pre-IDE meeting. Liver Machine Perfusion 
  Food and Drug Administration (FDA), Silver Springs, MD - 9/1/2010
• Liver Transplantation at the UPMC 
  McGowan Institute, University of Pittsburgh. - 3/1/2010
• Liver allocation under the UNOS system 
  University of Munster, Germany. 2nd MELD Meeting - 11/1/2009
• Future trends in organ preservation solutions 
  Essential Pharmaceuticals Board Meeting, Chicago, IL - 9/1/2009
• The liver transplant program 
  University of Pittsburgh Medical Center, Thomas E Starzl Transplantation Institute, Faculty Meeting - 7/1/2009
• Economics of Liver Transplantation 
  Grand Rounds, University of Sao Paulo, School of Medicine, Sao Paulo, Brazil - 6/1/2009
• 53. Invited panelist, program representative – UNOS consensus meeting on HCC 
  Chicago, IL - 11/1/2008
• 58th Annual Meeting, Invited Speaker 
  American College of Surgeons, 58th Annual Meeting, West Virginia Chapter, The Greenbrier, WV. - 5/1/2008
• Join now to see all

Other

• Gallblader dysplasia in chronic calculous cholecistitis. 
  Fortunato F, Fontes P
  11/1/1990
• Route of the infection in accute appendicitis. 
  Fernandes AON, Fontes P
  11/1/1990
• Gastric Dysplasia: Prospective study in gastrectomized patients. 
  Fontes PA
  Sao Paulo, Brazil - 11/1/1988
• Surgical treatment of ulcerative colitis with ileal "J" pouch: Analysis of 7 cases. 
  Fontes PA
  Sao Paulo, Brazil - 11/1/1987
• Gastric-esophageal reflux: Pathophysiology and Treatment. 
  Fontes PA, Menezes TC
  Sao Paulo, Brazil - 11/1/1986
• Join now to see all